Implementing the bispecific outpatient safe step-up (BOSS) program for elranatamab in ambulatory treatment of multiple myeloma.

Authors: Diana Cirstea, E. Bridget Kim, Sarah O'Neill, Kacthary Sanclemente, Matthew Lei, Alexis Barselau, Rajib Shome, Advait Joshi, Andrew J. Yee, Andrew Robert Branagan, Benjamin Puliafito, Noopur S. Raje

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.e19507

Source: Full article

---

Abstract

e19507